- Filed
- Jun 29, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · Jun 29, 2023 | 8.42M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2023 | 7.45M sh |
| Shares Diluted restated | Q1 2023 · Mar 31, 2022 | 3.11M sh |
| Operating Cash Flow | Q1 2023 · Mar 31, 2023 | −$9.85M |
| Operating Cash Flow | Q1 2023 · Mar 31, 2022 | −$4.57M |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $2.12M |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $12.04M |
| Stockholders Equity | Q1 2023 · Mar 31, 2023 | $22.55M |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | $11.83M |
| Stockholders Equity | Q1 2023 · Mar 31, 2022 | $25.84M |
| Stockholders Equity | Q1 2023 · Dec 31, 2021 | $29.45M |
| Current Liabilities | Q1 2023 · Mar 31, 2023 | $17.86M |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $21.42M |
| Total Liabilities | Q1 2023 · Mar 31, 2023 | $55.94M |
| Total Liabilities | Q1 2023 · Dec 31, 2022 | $62.17M |
| Current Assets | Q1 2023 · Mar 31, 2023 | $5.64M |
| Current Assets | Q1 2023 · Dec 31, 2022 | $17.86M |
| Total Assets | Q1 2023 · Mar 31, 2023 | $78.49M |
| Total Assets | Q1 2023 · Dec 31, 2022 | $101.11M |
| Eps Diluted | Q1 2023 · Mar 31, 2023 | −$2.94 |
| Eps Diluted restated | Q1 2023 · Mar 31, 2022 | −$1.34 |
| Eps Basic | Q1 2023 · Mar 31, 2023 | −$2.94 |
| Eps Basic restated | Q1 2023 · Mar 31, 2022 | −$1.34 |
| Sga Expense | Q1 2023 · Mar 31, 2023 | $4.92M |
| Sga Expense | Q1 2023 · Mar 31, 2022 | $2.4M |
| Rd Expense | Q1 2023 · Mar 31, 2023 | $4.99M |
| Rd Expense | Q1 2023 · Mar 31, 2022 | $1.78M |
| Net Income | Q1 2023 · Mar 31, 2023 | −$21.87M |
| Net Income | Q1 2023 · Mar 31, 2022 | −$4.18M |
| Operating Income | Q1 2023 · Mar 31, 2023 | −$20.61M |
| Operating Income | Q1 2023 · Mar 31, 2022 | −$4.18M |
| Short Term Debt | Q1 2023 · Jan 31, 2023 | $900K |